Global Hepatitis E Diagnostic Tests Market Size, Share, Trends, Industry Analysis Report: Information By Test Type (ELISA HEV IgM Test, ELISA HEV IgG Test, Rapid Diagnostics Test, and RT-PCR), By End User (Hospitals, Diagnostic Laboratories, Research Cent

Global Hepatitis E Diagnostic Tests Market Size, Share, Trends, Industry Analysis Report: Information By Test Type (ELISA HEV IgM Test, ELISA HEV IgG Test, Rapid Diagnostics Test, and RT-PCR), By End User (Hospitals, Diagnostic Laboratories, Research Centers, and Point-of-Care), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2024 - 2032



The global Hepatitis E diagnostic tests market size is expected to reach USD 78.62 million by 2032, according to a new study by Polaris Market Research. The report “Global Hepatitis E Diagnostic Tests Market Size, Share, Trends, Industry Analysis Report: By Test Type (ELISA HEV IgM Test, ELISA HEV IgG Test, Rapid Diagnostics Test, and RT-PCR), By End User (Hospitals, Diagnostic Laboratories, Research Centers, and Point-of-Care), And By Region (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) – Market Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global Hepatitis E diagnostic tests market is experiencing growth due to the rising incidence of Hepatitis E, especially in developing regions where poor sanitation and water contamination are prevalent. Advances in diagnostic technologies, such as PCR-based assays and point-of-care testing kits, are improving early detection and disease management. Major drivers of this market are the increasing prevalence of Hepatitis E, which demands more effective diagnostic solutions, and the growing awareness and governmental efforts towards disease prevention and control. Notable trends include the adoption of advanced molecular diagnostics and the expansion of diagnostic services in emerging markets to enhance accessibility and affordability.

In terms of competitive analysis, Abbott Laboratories and Roche stand out due to their extensive portfolios and strong presence in both developed and emerging markets.

Overall, the Hepatitis E diagnostic tests market is characterized by technological innovation, a focus on accessibility, and a response to the growing global burden of the disease, making it a dynamic and rapidly evolving sector within the healthcare industry.

Hepatitis E Diagnostic Tests Market Report Highlights:

The ELISA HEV IgM test segment is dominating the market during forecast period. This dominance is attributed to its widespread use in detecting acute Hepatitis E infection, as it identifies the presence of IgM antibodies produced in response to the infection.

RT-PCR segment is the highest-growing segment within the market during upcoming years. This growth is driven by the increasing demand for highly sensitive and specific diagnostic tools that can detect the presence of HEV RNA, enabling early and accurate diagnosis of the infection.

Hospitals are the dominating segment in this market, primarily due to their extensive infrastructure, availability of advanced diagnostic equipment, and a high volume of patients requiring diagnostic services.

The Point-of-Care segment is the highest-growing segment within the market. This rapid growth is fueled by the increasing demand for convenient and quick diagnostic solutions.

North America dominates the market, while Asia-Pacific is expected to witness the highest growth rate.

Polaris Market Research has segmented the Hepatitis E diagnostics tests market report based on test type, end user, and region:

Hepatitis E Diagnostic Tests, Type Outlook (Revenue - USD Million, 2019 - 2032)

ELISA HEV IgM Test

ELISA HEV IgG Test

Rapid Diagnostics Test

RT-PCR

Hepatitis E Diagnostic Tests, End User Outlook (Revenue - USD Million, 2019 - 2032)

Hospitals

Diagnostic Laboratories

Research Centers

Point-of-Care

Hepatitis E Diagnostic Tests, Regional Outlook (Revenue - USD Million, 2019 - 2032)

· North America

US

Canada

· Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

· Asia-Pacific

- China

- Japan

- India

- Malaysia

- South Korea

- Indonesia

- Australia

- Vietnam

- Rest of Asia-Pacific

· Middle East & Africa

- Saudi Arabia

- UAE

- Israel

- South Africa

- Rest of Middle East & Africa

· Latin America

- Mexico

- Brazil

- Argentina

- Rest of Latin America


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Hepatitis E Diagnostic Tests Market Insights
4.1. Hepatitis E Diagnostic Tests Market – Application Snapshot
4.2. Hepatitis E Diagnostic Tests Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Advancements in Diagnostic Technologies
4.2.1.2. Expansion in Emerging Markets
4.2.2. Restraints and Challenges
4.2.2.1. High Costs
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Hepatitis E Diagnostic Tests Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Hepatitis E Diagnostic Tests Market, by Tests Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
5.3. ELISA HEV IgM Test
5.3.1. Global Hepatitis E Diagnostic Tests Market, by ELISA HEV IgM Test, by Region, 2019-2032 (USD Million)
5.4. ELISA HEV IgG Test
5.4.1. Global Hepatitis E Diagnostic Tests Market, by ELISA HEV IgG Test, by Region, 2019-2032 (USD Million)
5.5. Rapid Diagnostics Test
5.5.1. Global Hepatitis E Diagnostic Tests Market, by Rapid Diagnostics Test, by Region, 2019-2032 (USD Million)
5.6. RT-PCR
5.6.1. Global Hepatitis E Diagnostic Tests Market, by RT-PCR, by Region, 2019-2032 (USD Million)
6. Global Hepatitis E Diagnostic Tests Market, by End Use
6.1. Key Findings
6.2. Introduction
6.2.1. Global Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
6.3. Hospitals
6.3.1. Global Hepatitis E Diagnostic Tests Market, by Hospitals, by Region, 2019-2032 (USD Million)
6.3.2. Diagnostic Laboratories
6.3.2.1. Global Hepatitis E Diagnostic Tests Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)
6.3.3. Research Centers
6.3.3.1. Global Hepatitis E Diagnostic Tests Market, by Research Centers, by Region, 2019-2032 (USD Million)
6.3.4. Point-of-Care
6.3.4.1. Global Hepatitis E Diagnostic Tests Market, by Point-of-Care, by Region, 2019-2032 (USD Million)
7. Global Hepatitis E Diagnostic Tests Market, by Geography
7.1. Key Findings
7.2. Introduction
7.2.1. Hepatitis E Diagnostic Tests Market Assessment, By Geography, 2019-2032 (USD Million)
7.3. Hepatitis E Diagnostic Tests Market – North America
7.3.1. North America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.3.2. North America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.3.3. Hepatitis E Diagnostic Tests Market – U.S.
7.3.3.1. U.S.: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.3.3.2. U.S.: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.3.4. Hepatitis E Diagnostic Tests Market – Canada
7.3.4.1. Canada: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.3.4.2. Canada: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.4. Hepatitis E Diagnostic Tests Market – Europe
7.4.1. Europe: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.4.2. Europe: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.4.3. Hepatitis E Diagnostic Tests Market – UK
7.4.3.1. UK: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.4.3.2. UK: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.4.4. Hepatitis E Diagnostic Tests Market – France
7.4.4.1. France: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.4.4.2. France: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.4.5. Hepatitis E Diagnostic Tests Market – Germany
7.4.5.1. Germany: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.4.5.2. Germany: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.4.6. Hepatitis E Diagnostic Tests Market – Italy
7.4.6.1. Italy: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.4.6.2. Italy: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.4.7. Hepatitis E Diagnostic Tests Market – Spain
7.4.7.1. Spain: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.4.7.2. Spain: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.4.8. Hepatitis E Diagnostic Tests Market – Netherlands
7.4.8.1. Netherlands: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.4.8.2. Netherlands: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.4.9. Hepatitis E Diagnostic Tests Market – Russia
7.4.9.1. Russia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.4.9.2. Russia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.4.10. Hepatitis E Diagnostic Tests Market – Rest of Europe
7.4.10.1. Rest of Europe: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.4.10.2. Rest of Europe: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.5. Hepatitis E Diagnostic Tests Market – Asia Pacific
7.5.1. Asia Pacific: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.5.2. Asia Pacific: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.5.3. Hepatitis E Diagnostic Tests Market – China
7.5.3.1. China: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.5.3.2. China: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.5.4. Hepatitis E Diagnostic Tests Market – India
7.5.4.1. India: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.5.4.2. India: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.5.5. Hepatitis E Diagnostic Tests Market – Malaysia
7.5.5.1. Malaysia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.5.5.2. Malaysia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.5.6. Hepatitis E Diagnostic Tests Market – Japan
7.5.6.1. Japan: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.5.6.2. Japan: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.5.7. Hepatitis E Diagnostic Tests Market – Indonesia
7.5.7.1. Indonesia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.5.7.2. Indonesia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.5.8. Hepatitis E Diagnostic Tests Market – South Korea
7.5.8.1. South Korea: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.5.8.2. South Korea: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.5.9. Hepatitis E Diagnostic Tests Market – Australia
7.5.9.1. Australia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.5.9.2. Australia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.5.10. Hepatitis E Diagnostic Tests Market – Rest of Asia Pacific
7.5.10.1. Rest of Asia Pacific: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.5.10.2. Rest of Asia Pacific: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.6. Hepatitis E Diagnostic Tests Market – Middle East & Africa
7.6.1. Middle East & Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.6.2. Middle East & Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.6.3. Hepatitis E Diagnostic Tests Market – Saudi Arabia
7.6.3.1. Saudi Arabia: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.6.3.2. Saudi Arabia: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.6.4. Hepatitis E Diagnostic Tests Market – UAE
7.6.4.1. UAE: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.6.4.2. UAE: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.6.5. Hepatitis E Diagnostic Tests Market – Israel
7.6.5.1. Israel: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.6.5.2. Israel: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.6.6. Hepatitis E Diagnostic Tests Market – South Africa
7.6.6.1. South Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.6.6.2. South Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.6.7. Hepatitis E Diagnostic Tests Market – Rest of Middle East & Africa
7.6.7.1. Rest of Middle East & Africa: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.6.7.2. Rest of Middle East & Africa: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.7. Hepatitis E Diagnostic Tests Market – Latin America
7.7.1. Latin America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.7.2. Latin America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.7.3. Hepatitis E Diagnostic Tests Market – Mexico
7.7.3.1. Mexico: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.7.3.2. Mexico: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.7.4. Hepatitis E Diagnostic Tests Market – Brazil
7.7.4.1. Brazil: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.7.4.2. Brazil: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.7.5. Hepatitis E Diagnostic Tests Market – Argentina
7.7.5.1. Argentina: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.7.5.2. Argentina: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
7.7.6. Hepatitis E Diagnostic Tests Market – Rest of Latin America
7.7.6.1. Rest of Latin America: Hepatitis E Diagnostic Tests Market, by Tests Type, 2019-2032 (USD Million)
7.7.6.2. Rest of Latin America: Hepatitis E Diagnostic Tests Market, by End Use, 2019-2032 (USD Million)
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Development
9.2. F. Hoffmann-La Roche Ltd
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Development
9.3. Siemens Healthineers
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Development
9.4. Bio-Rad Laboratories
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Development
9.5. Thermo Fisher Scientific
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Development
9.6. DiaSorin S.p.A.
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Development
9.7. Perkin Elmer Inc.
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Development
9.8. QIAGEN N.V.
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Development
9.9. bioMérieux SA
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Recent Development
9.10. Merck KGaA
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Development
9.11. Ortho Clinical Diagnostics
9.11.1. Company Overview
9.11.2. Financial Performance
9.11.3. Product Benchmarking
9.11.4. Recent Development
9.12. InBios International
9.12.1. Company Overview
9.12.2. Financial Performance
9.12.3. Product Benchmarking
9.12.4. Recent Development
9.13. Altona Diagnostics
9.13.1. Company Overview
9.13.2. Financial Performance
9.13.3. Product Benchmarking
9.13.4. Recent Development
9.14. Luminex Corporation
9.14.1. Company Overview
9.14.2. Financial Performance
9.14.3. Product Benchmarking
9.14.4. Recent Development
9.15. Randox Laboratories
9.15.1. Company Overview
9.15.2. Financial Performance
9.15.3. Product Benchmarking
9.15.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings